Fundraising FoxVelaris Therapeutics
1 known investors
Find your way into Velaris Therapeutics
Sign up to see every warm intro you have to Velaris Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Velaris Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Velaris Therapeutics develops ActRII-Fc ligand traps and complementary biologics to treat pulmonary hypertension and other cardiopulmonary diseases. Its portfolio is designed for monotherapies and combination therapies aimed at restoring balance in the growth-signaling pathways that drive these conditions.
Investors · 1
Frequently asked questions
- What does Velaris Therapeutics do?
- Velaris Therapeutics develops ActRII-Fc ligand traps and complementary biologics to treat pulmonary hypertension and other cardiopulmonary diseases. Its portfolio is designed for monotherapies and combination therapies aimed at restoring balance in the growth-signaling pathways that drive these conditions.
- Who are Velaris Therapeutics's investors?
- Velaris Therapeutics's investors include Access Biotechnology.